Back to today’s briefing

Story perspectives

TTAM Acquires 23andMe for $305M Amid Privacy Concerns

6/16/2025

47 7

Summary

Story summary

TTAM Research Institute, led by Anne Wojcicki, secured a $305 million acquisition of 23andMe, surpassing Regeneron Pharmaceuticals.
This acquisition comes after 23andMe's bankruptcy in March, prompting concerns about user data privacy.
TTAM pledges to uphold 23andMe's customer privacy policies despite ongoing lawsuits from multiple states.
Wojcicki highlights the significance of consumer choice and transparency in managing genetic data.

1 of 1

Story summary

TTAM Research Institute, led by Anne Wojcicki, secured a $305 million acquisition of 23andMe, surpassing Regeneron Pharmaceuticals.
This acquisition comes after 23andMe's bankruptcy in March, prompting concerns about user data privacy.
TTAM pledges to uphold 23andMe's customer privacy policies despite ongoing lawsuits from multiple states.
Wojcicki highlights the significance of consumer choice and transparency in managing genetic data.